Indans
"Indans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES.
Descriptor ID |
D007189
|
MeSH Number(s) |
D02.455.426.559.847.486.487 D04.615.486.487
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Indans".
Below are MeSH descriptors whose meaning is more specific than "Indans".
This graph shows the total number of publications written about "Indans" by people in UAMS Profiles by year, and whether "Indans" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2023 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 | 2015 | 0 | 1 | 1 | 2013 | 1 | 0 | 1 | 2007 | 1 | 1 | 2 | 2006 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Indans" by people in Profiles over the past ten years.
-
Olanow CW, Hauser RA, Burdick DJ, Dhall R, de Marcaida JA, Gil RA, Kreitzman DL, Elmer LW, McGarry A, Kieburtz K. A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease. Mov Disord. 2024 Feb; 39(2):350-359.
-
Balasubramaniam M, Lakkaniga NR, Dera AA, Fayi MA, Abohashrh M, Ahmad I, Chandramoorthy HC, Nalini G, Rajagopalan P. FCX-146, a potent allosteric inhibitor of Akt kinase in cancer cells: Lead optimization of the second-generation arylidene indanone scaffold. Biotechnol Appl Biochem. 2021 Feb; 68(1):82-91.
-
Rajagopalan P, Alahmari KA, Elbessoumy AA, Balasubramaniam M, Suresh R, Shariff ME, Chandramoorthy HC. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer. Cancer Chemother Pharmacol. 2016 Feb; 77(2):393-404.
-
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol. 2015 Aug; 14(8):795-803.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|